We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

248 hedge funds and large institutions have $4.65B invested in Sage Therapeutics in 2020 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 74 increasing their positions, 85 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 33

43% more capital invested

Capital invested by funds: $3.26B → $4.65B (+$1.39B)

18% more call options, than puts

Call options by funds: $54.8M | Put options by funds: $46.6M

8% more funds holding

Funds holding: 230 → 248 (+18)

0.12% more ownership

Funds ownership: 103.25% → 103.37% (+0.12%)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

13% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 85

Holders
248
Holders Change
+18
Holders Change %
+7.83%
% of All Funds
4.39%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
51
Increased
74
Reduced
85
Closed
33
Calls
$54.8M
Puts
$46.6M
Net Calls
+$8.17M
Net Calls Change
-$24.4M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$298M
2
Deutsche Bank
Deutsche Bank
Germany
+$32.5M
3
PA
Perceptive Advisors
New York
+$32.4M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$26.5M
5
MWNA
Marshall Wace North America
New York
+$22.1M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$111M
2
Citadel Advisors
Citadel Advisors
Florida
-$68.2M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$36.9M
4
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
-$30.5M
5
Victory Capital Management
Victory Capital Management
Texas
-$25.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
LJHT
226
Laurie J. Hall Trustee
$7K – – –
MAM
227
Meeder Asset Management
Ohio
$7K – – –
SBL
228
Sargent Bickham Lagudis
Colorado
$7K – – –
QCG
229
Quadrant Capital Group
Ohio
$7K +$1.11K +15 +23%
CCA
230
Childress Capital Advisors
Texas
$6K +$4.79K +65 New
LC
231
Lindbrook Capital
California
$4K – – –
LWCFA
232
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$4K – – –
WLPWM
233
Walled Lake Planning & Wealth Management
Illinois
$4K – – –
TPCW
234
TD Private Client Wealth
New York
$2.34K +$884 +12 +80%
ABC
235
Associated Banc-Corp
Wisconsin
$2K – – –
BWM
236
BerganKDV Wealth Management
Minnesota
$2K – – –
EARNEST Partners
237
EARNEST Partners
Georgia
$2K – – –
TFO
238
Tarbox Family Office
California
$2K – – –
Carson Wealth (CWM LLC)
239
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
JCM
240
Jacobi Capital Management
Pennsylvania
$1K – – –
Northwestern Mutual Wealth Management
241
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
RPWA
242
Regent Peak Wealth Advisors
Georgia
$1K +$590 +8 New
VCG
243
Vantage Consulting Group
Virginia
$1K +$884 +12 New
EFSCE
244
Enterprise Financial Services Corp (EFSC)
Missouri
$1K +$1.03K +14 New
NSIM
245
North Star Investment Management
Illinois
$1K +$1.03K +14 New
WAM
246
Wolverine Asset Management
Illinois
$1K +$1.18K +16 New
WIM
247
Westside Investment Management
California
$235 -$77.4K -1,050 -28%
AIG
248
American International Group
New York
$61 -$516 -7 -1%
BCLSI
249
Bain Capital Life Sciences Investors
Massachusetts
– -$30.5M -499,100 Closed
VC
250
Vivo Capital
California
– -$21.6M -353,511 Closed
8 9
10
11 12

SAGE Hedge Fund Activity: Q4 2020 in Review

248 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2020, worth a combined $4.65B — up 43% from $3.26B a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new SAGE positions and 33 closed out — a net gain of 18 holders — while 74 added to existing stakes and 85 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $298M. The largest seller was Great Point Partners, cutting an estimated $111M.

  • 248 institutional investors held Sage Therapeutics (SAGE) as of Q4 2020, up from 230 in Q3 2020.
  • Funds reported $4.65B of Sage Therapeutics stock for Q4 2020, up 43% quarter-over-quarter.
  • 51 funds opened new Sage Therapeutics positions in Q4 2020 and 33 closed out, a net change of +18 holders.
  • The largest Sage Therapeutics buyer in Q4 2020 was Wellington Management Group, an estimated $298M added.
  • The largest Sage Therapeutics seller in Q4 2020 was Great Point Partners, an estimated $111M sold.

Based on aggregated 13F filings for Q4 2020.